Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2007-04-12 23:21:17 UTC |
---|
Update Date | 2022-03-07 02:49:30 UTC |
---|
HMDB ID | HMDB0006111 |
---|
Secondary Accession Numbers | - HMDB0004698
- HMDB04698
- HMDB06111
|
---|
Metabolite Identification |
---|
Common Name | 12-HETE |
---|
Description | 12-Hydroxyeicosatetraenoic acid (CAS: 71030-37-0), also known as 12-HETE, is an eicosanoid, a 5-lipoxygenase metabolite of arachidonic acid. 5-Lipoxygenase (LO)-derived leukotrienes are involved in inflammatory glomerular injury. LO product 12-HETE is associated with the pathogenesis of hypertension and may mediate angiotensin II and TGFbeta induced mesangial cell abnormality in diabetic nephropathy. 12-HETE is markedly elevated in the psoriatic lesions. 12-HETE is a vasoconstrictor eicosanoid that contributes to high blood pressure in (renovascular) hypertension and pregnancy-induced hypertension. A significant percentage of patients suffering from a selective increase in plasma LDL cholesterol (type IIa hyperlipoproteinemia) exhibits increased platelet reactivity. This includes enhanced platelet responsiveness against a variety of platelet-stimulating agents ex vivo and enhanced arachidonic acid metabolism associated with increased generation of arachidonic acid metabolites such as 12-HETE, and secretion of platelet-storage products (PMID: 7562532 , 12480795 , 17361113 , 8498970 , 1333255 , 2119633 ). 12-HETE is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumour cell metastatic potential through activation of protein kinase C. 12-HETE has a diversity of biological actions and is generated by a number of tissues including the renal glomerulus and the vasculature. 12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. 12-HETE is a neuromodulator that is synthesized during ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as well as inhibition of AMPA receptor (AMPA-R) activation. 12-HETE is found to be associated with peroxisomal biogenesis defect and Zellweger syndrome, which are inborn errors of metabolism. |
---|
Structure | CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O InChI=1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(12S)-12-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoic acid | ChEBI | (5Z,8Z,10E,12S,14Z)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid | ChEBI | (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid | ChEBI | (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoic acid | ChEBI | 12(S)-Hydroxy-5(Z),8(Z),10(e),14(Z)-eicosatetraenoic acid | ChEBI | 12(S)-Hydroxy-5,8,14(Z),10(e)-eicosatetraenoic acid | ChEBI | 12(S)-Hydroxyeicosatetraenoic acid | ChEBI | 12S-HETE | ChEBI | (12S)-12-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoate | Generator | (5Z,8Z,10E,12S,14Z)-12-Hydroxyeicosa-5,8,10,14-tetraenoate | Generator | (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoate | Generator | (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoate | Generator | 12(S)-Hydroxy-5(Z),8(Z),10(e),14(Z)-eicosatetraenoate | Generator | 12(S)-Hydroxy-5,8,14(Z),10(e)-eicosatetraenoate | Generator | 12(S)-Hydroxyeicosatetraenoate | Generator | (5Z,8Z,10E,14Z)-12-Hydroxy-5,8,10,14-eicosatetraenoic acid | HMDB | 12(S)-HETE | HMDB | 12(S)-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoic acid | HMDB | 12-Hydroxy-5,8,10,14-eicosatetraenoic acid | HMDB | 12-Hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid | HMDB | 12-Hydroxyeicosatetraenoic acid | HMDB | 12-L-Hydroxy-5,8,10,14-eicosatetraenoic acid | HMDB | 12S-Hydroxy-5,8,10,14-(Z,Z,e,Z)-eicosatetraenoic acid | HMDB | FA(20:4(5Z,8Z,10E,12-OH,14Z)) | HMDB | FA(20:4(5Z,8Z,10E,12S-OH,14Z)) | HMDB |
| Show more...
---|
Chemical Formula | C20H32O3 |
---|
Average Molecular Weight | 320.4663 |
---|
Monoisotopic Molecular Weight | 320.23514489 |
---|
IUPAC Name | (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid |
---|
Traditional Name | 12S-hete |
---|
CAS Registry Number | 54397-83-0 |
---|
SMILES | CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O |
---|
InChI Identifier | InChI=1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1 |
---|
InChI Key | ZNHVWPKMFKADKW-LQWMCKPYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Hydroxyeicosatetraenoic acids |
---|
Alternative Parents | |
---|
Substituents | - Hydroxyeicosatetraenoic acid
- Long-chain fatty acid
- Hydroxy fatty acid
- Fatty acid
- Unsaturated fatty acid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
12-HETE,1TMS,isomer #1 | CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O[Si](C)(C)C | 2737.0 | Semi standard non polar | 33892256 | 12-HETE,1TMS,isomer #2 | CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C | 2633.5 | Semi standard non polar | 33892256 | 12-HETE,2TMS,isomer #1 | CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2706.2 | Semi standard non polar | 33892256 | 12-HETE,1TBDMS,isomer #1 | CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 2983.3 | Semi standard non polar | 33892256 | 12-HETE,1TBDMS,isomer #2 | CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C | 2875.1 | Semi standard non polar | 33892256 | 12-HETE,2TBDMS,isomer #1 | CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3192.4 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 12-HETE GC-MS (Non-derivatized) - 70eV, Positive | splash10-0lxy-8892000000-af669345c2f07af6464f | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 12-HETE GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 10V, Positive-QTOF | splash10-0udi-0149000000-30d66ea8fabdf9ad8be7 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 20V, Positive-QTOF | splash10-1170-5894000000-a08e2339ff5012eb70cb | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 40V, Positive-QTOF | splash10-05mo-9630000000-1125d69108467f1388e5 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 10V, Negative-QTOF | splash10-014i-0019000000-a230e97019aecf4548b9 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 20V, Negative-QTOF | splash10-0uxr-1249000000-3b11e114d7aa3c180372 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 40V, Negative-QTOF | splash10-0a4l-9820000000-08efc5f37c4b2f87360c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 10V, Negative-QTOF | splash10-014i-0009000000-9fc7e9714470f0f9624f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 20V, Negative-QTOF | splash10-0gb9-0419000000-cd9d67d0c1bba959fe5c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 40V, Negative-QTOF | splash10-0596-9581000000-d70c346b7a187ee4a266 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 10V, Positive-QTOF | splash10-0udi-0349000000-af69d38890bc80fda3a3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 20V, Positive-QTOF | splash10-0k9i-5932000000-f79082fedeb294426f6f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-HETE 40V, Positive-QTOF | splash10-05mo-9410000000-8748c14268773fb5c2fd | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-21 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.00422 +/- 0.000292 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.35 +/- 0.25 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00642 +/- 0.00074 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0526 +/- 0.0944 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00395 +/- 0.0033 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0 - 0.001 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00091 +/- 0.00031 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0-0.00000001560 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 0.000012138 +/- 0.0000035633 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0-1.560e-08 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details |
| Show more...
---|
Abnormal Concentrations |
---|
| |
Cerebrospinal Fluid (CSF) | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Cerebral Vasospasm | | details | Urine | Detected and Quantified | 0.000000078 (0.00-0.000000156) umol/mmol creatinine | Adult (>18 years old) | Both | Peroxisomal biogenesis defect | | details | Urine | Detected and Quantified | 0.00001248 (0.0000090000-0.00001903) umol/mmol creatinine | Infant (0-1 year old) | Both | Zellweger syndrome | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Cerebral vasospasm |
---|
- Poloyac SM, Reynolds RB, Yonas H, Kerr ME: Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. J Neurosci Methods. 2005 Jun 15;144(2):257-63. Epub 2004 Dec 30. [PubMed:15910986 ]
| Peroxisomal biogenesis defect |
---|
- Mayatepek E, Lehmann WD: 12- and 15-hydroxyeicosatetraenoic acid are excreted in the urine of peroxisome-deficient patients: evidence for peroxisomal metabolism in vivo. Pediatr Res. 1996 Jan;39(1):146-9. [PubMed:8825400 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
|
|
---|
Associated OMIM IDs | - 214100 (Peroxisomal biogenesis defect)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00000424 |
---|
Chemspider ID | 4446279 |
---|
KEGG Compound ID | C14777 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | 12-Hydroxyeicosatetraenoic acid |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5283155 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 34146 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 12HARACHD |
---|
MarkerDB ID | MDB00000482 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Diaz A, Ruiz F, Florez J, Hurle MA, Pazos A: Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J Pharmacol Exp Ther. 1995 Sep;274(3):1545-51. [PubMed:7562532 ]
- Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505. [PubMed:12480795 ]
- Hao CM, Breyer MD: Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 2007 Jun;71(11):1105-15. Epub 2007 Mar 14. [PubMed:17361113 ]
- Schror K: Prostaglandin-mediated actions of the renin-angiotensin system. Arzneimittelforschung. 1993 Feb;43(2A):236-41. [PubMed:8498970 ]
- Ruzicka T: The role of the epidermal 12-hydroxyeicosatetraenoic acid receptor in the skin. Eicosanoids. 1992;5 Suppl:S63-5. [PubMed:1333255 ]
- Schror K: Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification by cholesterol-lowering agents. Eicosanoids. 1990;3(2):67-73. [PubMed:2119633 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|